- Presentations
- 5
- Markets
- 2
Isentress is a brand of Raltegravir marketed by Merck Sharp & Dohme, with 5 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Raltegravir
- Brand owner
- Merck Sharp & Dohme
- Registered in
- European Union, United States
- Strengths and forms
- 100 mg chewable tablet, 25 mg chewable tablet, 100 mg oral suspension, 400 mg tablet, 600 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Isentress 100 mg chewable tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Isentress 25 mg chewable tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Isentress 100 mg oral suspensionOral | Merck Sharp & Dohme | US FDA | Available on request |
| Isentress 400 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
| Isentress 600 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Isentress
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.